|
J Biol Chem, Vol. 275, Issue 12, 8572-8581, March 24, 2000
Characterization of the Selectivity Filter of the Epithelial
Sodium Channel*
Shaohu
Sheng ,
Jinqing
Li ,
Kathleen A.
McNulty,
Daniel
Avery, and
Thomas R.
Kleyman§
From the Departments of Medicine and Physiology, School of
Medicine, University of Pennsylvania and the Veteran Affairs Medical
Center, Philadelphia, Pennsylvania 19104
 |
ABSTRACT |
The epithelial sodium channel (ENaC) is composed
of three homologous subunits termed , , and . Previous studies
suggest that selected residues within a hydrophobic region immediately preceding the second membrane-spanning domain of each subunit contribute to the conducting pore of ENaC. We probed the pore of mouse
ENaC by systematically mutating all 24 amino acids within this putative
pore region of the -subunit to cysteine and co-expressing these
mutants with wild type - and -subunits of mouse ENaC in Xenopus laevis oocytes. Functional characteristics of these
mutants were examined by two-electrode voltage clamp and single channel recording techniques. Two distinct domains were identified based on the
functional changes associated with point mutations. An amino-terminal
domain ( -Val569- -Gly579) showed minimal
changes in cation selectivity or amiloride sensitivity following
cysteine substitution. In contrast, cysteine substitutions within the
carboxyl-terminal domain
( -Ser580- -Ser592) resulted in
significant changes in cation selectivity and moderately altered
amiloride sensitivity. The mutant channels containing G587C or
S589C were permeable to K+, and mutation of a GSS tract
(positions 587- 589) to GYG resulted in a moderately
K+-selective channel. Our results suggest that the
C-terminal portion of the pore region within the -subunit
contributes to the selectivity filter of ENaC.
 |
INTRODUCTION |
Epithelial sodium channels
(ENaCs)1 mediate sodium
transport across apical plasma membranes of epithelial cells that line
the distal nephron, the airway and alveoli, and the distal colon. ENaCs
are composed of three homologous subunits, termed -, -, and
ENaC (1, 2) and have a subunit stoichiometry of 2: 1: 1 (3,
4) (Fig. 1B), although some reports have suggested an alternative subunit stoichiometry (5, 6). The three subunits have a
similar topology, with cytoplasmic amino and carboxyl termini and two
transmembrane domains (termed M1 and M2) that are separated by a large
ectodomain (Fig. 1A) (7-9). Hydropathy analyses revealed two rather hydrophobic regions (termed H1 and H2) immediately following
M1 and preceding M2 (2). The region preceding M2 may enter the
membrane, similar to the pore-forming region (P region) of the
voltage-gated Na+, K+, and Ca2+
channels (9).
Mutagenesis of selected residues within the H2 region and the segment
between H2 and M2 of the -, -, or -subunits of ENaC resulted
in changes in cation selectivity, single channel conductance, or
sensitivity to amiloride, a putative pore blocker of ENaC (4, 10-13).
These findings argued that all three subunits are involved in pore
formation and that the region preceding the M2 domain forms a portion
of the pore. Snyder et al. (14) recently reported a study
describing the results of scanning mutagenesis of the pore region of
the -subunit of human ENaC. Both Snyder et al. and
Kellenberger et al. (11, 12, 14) have suggested that the
pore structure of ENaC is distinct from that of KcsA, a K+
channel whose structure was resolved by x-ray crystallography (15).
In this report, we refer to the hydrophobic region preceding the M2
domain as the pore (or P) region of ENaC. We have systematically mutated all 24 residues (Val569-Ser592) within
the pore region to cysteine in order to identify residues within the
mouse -subunit that participate in forming the ENaC pore. The
mutated -subunits of mENaC were co-expressed with wild type - and
-subunits of mENaCs in Xenopus oocytes in order to identify mutations that affect functional characteristics of the channel pore. Mutations that led to changes in cation selectivity and
amiloride sensitivity were largely restricted to the 13 residues within
the carboxyl-terminal portion of the pore region of mENaC. Our
studies indicate that the C-terminal domain within the putative pore
region of the -subunit contributes to the selectivity filter of
ENaC.
 |
EXPERIMENTAL PROCEDURES |
Reagents--
All chemicals were from Sigma unless stated otherwise.
Site-directed Mutagenesis--
Three subunits for mouse ENaC
( -, -, and mENaC) cDNAs were cloned into pBluescript
SK( ) (Stratagene, La Jolla, CA) from a mouse kidney cDNA library
(16). All amino acids in the pore region of mENaC
( -Val569- -Ser592) were replaced
individually by cysteine residues through site-directed mutagenesis
with the sequential polymerase chain reaction method using
Pfu DNA polymerase (Stratagene) (4, 17). The polymerase chain reaction-amplified fragments containing the desired mutations were digested with BsmI and BspEI (New England
Biolabs Inc., Beverly, MA) and ligated to wild type cDNA vector
that had been digested with the same two restriction enzymes. The
subcloned fragment was sequenced in entirety by automated DNA
sequencing at the University of Pennsylvania Sequencing Facility to
confirm the desired mutation.
Expression in Xenopus Oocytes--
cRNAs for wild type and
mutant mENaC, wild type mENaC, and mENaC were synthesized from
linearized DNAs with T3 RNA polymerase (Ambion Inc.,
Austin, TX) and stored at 80 °C. Stage V-VI Xenopus oocyte pretreated with 2 mg/ml collagenase (type IV) was injected with
2-4 ng/subunit of cRNAs in 50 nl of H2O (16). After
injection, oocytes were incubated at 18 °C in modified Barth's
saline (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 15 mM HEPES, 0.3 mM Ca (NO3)2, 0.41 mM
CaCl2, 0.82 mM MgSO4, 10 µg/ml
sodium penicillin, 10 µg/ml streptomycin sulfate, 100 µg/ml
gentamycin sulfate, pH 7.2). Two-electrode voltage clamp and patch
clamp recordings were performed 20-72 h after injection at room
temperature (22-25 °C).
Two-electrode Voltage Clamp--
Two-electrode voltage clamp was
performed using a DigiData 1200 interface (Axon Instruments, Foster
City, CA) and a TEV 200 Voltage Clamp amplifier (Dagan Corp.,
Minneapolis, MN). Data acquisition and analyses were performed using
pClamp 6.03 software (Axon Instruments) on a 120-MHz Pentium PC
(Gateway 2000 Inc., N. Sioux City, SD). Pipettes were pulled from
borosilicate glass capillaries (World Precision Instruments, Inc.,
Sarasota, FL) with a Micropipette Puller (Sutter Instrument Co.,
Novato, CA) and had resistance of 0.5-5 megaohms when filled with 3 M KCl and inserted into the bath solution. Oocytes were
maintained in a recording chamber with 1 ml of bath solution and
continuously perfused with bath solution at a flow rate of 4-5 ml/min.
The bath solution used for the measurement of amiloride sensitivity
contained 100 mM sodium gluconate, 2 mM KCl,
1.8 mM CaCl2, 5 mM
BaCl2, 10 mM HEPES, pH 7.2. For most
experiments, a series of voltage steps (450 or 900 ms) from 140 to
+40 mV in 20-mV increments were performed, and whole cell currents were
measured at 400 or 800 ms, respectively, after initiation of the
voltage step. Amiloride-sensitive currents were defined as the current
difference in the absence and presence of amiloride (100 µM or 1 mM) in the bath solution (16).
Amiloride was prepared in bath solution and delivered to the oocyte by
perfusion. To determine the inhibition constant (Ki)
of amiloride, sodium gluconate bath solutions containing
10 8, 10 7, 10 6,
10 5, 10 4, and 10 3
M amiloride were sequentially perfused into the recording
chamber, and inward currents were recorded before and after each
application of amiloride. Amiloride Ki was
determined by nonlinear regression analysis (Origin 5, MicroCal Inc.,
Northampton, MA) using the following equation,
|
(Eq. 1)
|
where I and Io are Na+
currents measured in the presence and absence of amiloride,
respectively, [A] is the amiloride concentration, and n'
is the pseudo-Hill coefficient.
For selectivity experiments, separate bath solutions containing
Na+, Li+, or K+ as the predominant
cation were used. These solutions all contained the gluconate salt of
Na+, Li+, or K+ at a concentration
of 100 mM, 1.8 mM CaCl2, 5 mM BaCl2, and 10 mM HEPES. The pH
was adjusted to 7.2 with NaOH, LiOH, or KOH, respectively. The
K+, Na+, and Li+ solutions were
sequentially used to bathe the oocytes under continuous perfusion.
Oocytes were subsequently bathed in these solutions in the presence of
100 µM amiloride. Macroscopic currents were recorded with
each bath solution when a stable membrane potential was observed
(typically 2-3 min after initial application of the bath solution).
Amiloride-sensitive currents recorded at 100 mV were used to
calculate the ratios of K+ current
(IK) and Li+ current
(ILi) relative to Na+ current
(INa).
Single Channel Recording--
Bath and pipette solutions were
identical and contained 110 mM LiCl or NaCl, 1 mM CaCl2, 1 mM MgCl2,
10 mM HEPES, pH 7.4, adjusted with LiOH or NaOH,
respectively. Oocytes were placed in a hypertonic solution (bath
solution supplemented with 200 mM sucrose) for 3-5 min,
and vitelline membranes were then removed manually. Oocytes were then
transferred to the bath solution and maintained at room temperature
(22-25 °C) for at least 30 min before recording. Patch pipettes
were pulled in multiple steps and fire-polished with a Micro Forge
(Narishige, Japan). Pipettes with tip resistance of 10-30 mega ohms
were chosen for patch clamping. Currents were recorded in the
cell-attached configuration using PC-ONE Patch Clamp Amplifier (Dagan)
and DigiData 1200 interface (Axon) connected to a Pentium II 330-MHz PC
(Gateway 2000 Inc.). Single channel recording data were acquired using
pClamp 7.0 (Axon) for Microsoft Windows 95 (Microsoft Inc.) at 5 kHz,
filtered at 300 Hz by a three-pole low pass Bessel Filter built in the
amplifier, and stored on the hard drive disc. To determine single
channel conductance, averaged currents recorded at intracellular
voltages of 40, 60, 80, and 100 mV were plotted against the
applied voltage, and slope conductance was determined by linear curve fitting using MS Excel 97 (Microsoft).
Statistical Analyses--
Data are expressed as mean ± S.E. Student's t test was performed for significance
analysis between wild type and mutant channel with MS Excel 97.
 |
RESULTS |
Expression of Channels with Cysteine Substitutions within the Pore
Region of mENaC in Oocytes--
Recent studies suggest that
residues immediately preceding the predicted -helical second
membrane spanning domain (M2) of the -, - and -subunit of ENaC
form part of the channel pore (4, 10-13). The amino acid residues
within this region are illustrated in Fig.
1C and are aligned with
residues of other members of the ENaC/degenerin family. This region is
highly conserved, as expected for a region that might have a critical
role in forming the pore of these channels. Each ENaC subunit has two
well defined, long hydrophobic domains (2). We used several algorithms
to predict the secondary structure of the long second hydrophobic
domain containing the putative pore and M2 regions of mENaC. The
amino-terminal portion, corresponding to pore region, was predicted to
contain both extended and random coiled structures. The
carboxyl-terminal portion of this second hydrophobic domain, comprising
the -helical second membrane spanning domain (M2), was predicted to
begin between residues -Val590 and
-Ser592 (Fig. 1D). We define the pore (or P)
region of mENaC to include residues from Val569 to
Ser592.

View larger version (73K):
[in this window]
[in a new window]
|
Fig. 1.
Topology, subunit stoichiometry, and pore
sequence alignments of ENaC. A, proposed topology for
one ENaC subunit. The pore region is shaded. B,
subunit stoichiometry of ENaC. The channel is a heterotetramer, formed
by two subunits, one subunit, and one subunit, with the two
subunits facing each other. C, amino acid sequence
alignments of the pore regions of -, -, and mENaC
(GenBankTM accession nos. AF112185, AF112186, and
AF112187), human ENaC ( -subunit of human ENaC;
GenBankTM accession no. U38254), FaNaCh
(FMRFamide-activated amiloride-sensitive sodium channel;
GenBankTM accession no. X92113), DEG-1 (degenerin from
Caenorhabditis elegans; GenBankTM
accession no. L34414), MEC-4 (mechanosensitive protein from C. elegans, GenBankTM accession no. U53669), hBNaC1
(human brain sodium channel; GenBankTM accession no.
U57352), and ASIC1 (acid-sensing ion channel 1, or proton-gated cation
channel 1; GenBankTM accession no. U94403). The multiple
sequence alignment was performed with MacVector version 6.5 (MacVector)
on a PowerPC (Apple). Identical amino acids are shaded, and
similar residues are boxed. The amino acids
Val569-Ser592 from mENaC that were mutated
in the present study are shown on the top line.
D, secondary structural predictions of the regions including
and adjacent to the second membrane-spanning domain (M2) of mENaC
(residues Pro567-Pro622) were performed by
Network Protein Sequence Analysis (available on the World Wide Web).
h (boldface type), -helix;
e, extended strand; t, -turn; c,
random coil; ?, ambiguous site. Prediction methods are DSC
(45), GOR1 (46), GOR3 (47), MLRC (48), PHD (49), and Predator (50). The
consensus prediction (Sec. Cons.) is shown in the
bottom line. The boxed area
indicates a region where all methods predict an -helical
domain.
|
|
All 24 residues ( -Val569 to -Ser592)
within the pore region of mENaC were systematically mutated to
cysteine. The functional characteristics of these mutations within
mENaC were determined by co-expression with wild type - and
mENaC in Xenopus oocytes. Whole cell amiloride-sensitive
Na+ currents were readily detected following expression of
22 of the 24 mutant channels, in the range of 4 to 40 µA at a
test potential of 100 mV. Levels of current expression observed with two mutant channels, G587C and S589C , were less than
200 nanoamperes (nA), differed markedly from that observed with wild type and other -subunit mutants, and did not increase when
Ba2+ was removed from the bath solution (data not shown).
Mutations within the Carboxyl-terminal Domain of the Pore Region of
mENaC Alter Amiloride Sensitivity--
The inhibition constants for
amiloride were determined for wild type   mENaC and for the
mutant mENaCs (Fig. 2A).
Modest increases in the Ki for amiloride, in the
range of 1.7-3.5-fold, were observed with 8 of 13 mutations within the
carboxyl-terminal portion of the pore domain (residues
-Ser580- -Ser592). Given the low
magnitude of whole cell currents observed in oocytes expressing the
G587C or S589C , Ki values for
amiloride were not determined for these mutants. However, the relative
inhibition observed with 100 nM and 100 µM
amiloride suggested that their amiloride sensitivity was similar to
that of wild type mENaC (data not shown). Only one of the cysteine mutations ( L575C) within the amino-terminal portion of the pore region (residues -Val569- -Gly579)
exhibited a Ki for amiloride (53 ± 5 nM, n = 4) that differed from wild type.
Amiloride dose-response curves for wild type   mENaC and
selected -subunit mutations within the pore region are illustrated
in Fig. 2B.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
Effects of mutations on amiloride inhibitory
constants (Ki values). A,
amiloride Ki values for wild type and mutant mENaCs.
Macroscopic Na+ currents were measured at the test
potential of 100 mV in the absence or presence of increasing
concentrations of amiloride in a sodium gluconate bath solution. The
amiloride Ki was determined by nonlinear least
squares fitting of dose-response data. B, dose-response
curves of amiloride blockade for wild type ( ), W582C ( ),
L584C ( ), F586C ( ), and S588C ( )
mENaC. Values and error bars represent the
mean ± S.E. for 3-8 oocytes. Lines were created by
curve fitting of the data. The p values for comparing mutant
and wild type channels are as follows. *, p < 0.05;
**, p < 0.01. ND, amiloride
Ki was not determined for G587C and
S589C.
|
|
Mutations within the C-terminal Domain of the Pore Region of
mENaC Alter Cation Selectivity--
The cation selectivities for
both wild type   mENaC and mutant mENaCs were determined by
measuring amiloride-sensitive inward currents in oocytes by
two-electrode voltage clamp in K+, Na+, and
Li+ bath solutions. Wild type   mENaC exhibited an
amiloride-sensitive Li+/Na+ current ratio of
1.68 ± 0.06 (n = 16), and an amiloride-sensitive K+/Na+ current ratio of 0.01 ± 0.01 (n = 16) (Table II and Figs.
3 and 4).
No amiloride-sensitive currents were observed in water-injected oocytes
(data not shown). The selectivity sequence of Li+ > Na+ K+ observed for   mENaC is
consistent with that observed with epithelial Na+ channels
from other species (2, 18-23).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Cation selectivity of wild type mENaC.
A, representative whole cell recordings of wild type mENaC
in the presence of K+, Na+, and Li+
solutions as described under "Experimental Procedures." The oocyte
was injected with 4 ng of -, -, and mENaC cRNAs and was
voltage-clamped for 900 ms from 140 to +40 mV in 20-mV increments.
Currents represent amiloride-sensitive currents obtained by subtraction
of currents in the presence of 100 µM amiloride from the
currents in the absence of amiloride. B, current-voltage
relationship of wild type mENaC from the same oocyte as in
A. Amiloride-sensitive currents in the presence of
K+ ( ), Na+ ( ), and Li+ ( )
were plotted against test potentials in the range of 140 to +40
mV.
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 4.
Current ratios of wild type
(WT) and mutant mENaCs. A, oocytes
injected with wild or mutant cRNAs, and
ILi/INa was calculated
from amiloride-sensitive currents measured at 100 mV in the presence
of a Li+ or Na+ bath solution. B,
IK/INa was determined
from amiloride-sensitive currents measured at 100 mV in the presence
of a K+ or Na+ bath solution. Data are
presented as mean ± S.E. from 16 oocytes for wild type and 4-9
oocytes for mutants. The p values from Student's
t tests between wild type and mutant channels are as
follows. *, p < 0.05; **, p < 0.01;
***, p < 0.001.
|
|
The ratios of ILi/INa and
IK/INa for both wild type
and mutant channels measured at a testing potential of 100 mV are
illustrated in Fig. 4. Substitution of cysteine residues within the
amino-terminal portion of the pore region of mENaC ( V569C to
G579C) did not produce alterations of
Li+/Na+ and K+/Na+
current ratios, with the exception of S573C. This mutant showed a
modest reduction in the Li+/Na+ current ratio,
when compared with wild type mENaC. These results suggest that these
residues are not essential for maintaining the characteristic cation
selectivity of ENaC. In contrast, five mutations within the
carboxyl-terminal portion of the pore domain ( S580C, W582C,
L584C, F586C, and S592C) significantly altered the
Li+/Na+ current ratio (Figs. 4 and
5). Two mutants in this region ( G587C and S589C) were K+-permeable (Fig. 4). These results
suggest that multiple residues within the carboxyl-terminal portion of
the pore region of ENaC are involved in the ionic permeation
mechanism of ENaC.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 5.
Point mutations altered
Li+/Na+ selectivity. Current-voltage
relationships of wild type (WT) mENaC, S580C ,
W582C , L584C , F586C , and S592C were
obtained by plotting amiloride-sensitive currents measured in the
presence of K+ ( ), Na+ ( ), or
Li+ ( ) bath solutions against test potentials in the
range of 140 to +40 mV, in 20-mV increments, without curve fitting.
Data are presented as mean ± S.E. from 10 oocytes for wild type
and 4-9 oocytes for mutants.
|
|
Cell-attached patch clamp was performed using Li+ as the
permeating ion in order to determine whether the changes in
Li+/Na+ selectivity reflected changes in
Li+ permeation. Of the 12 mutants examined, the single
channel Li+ conductance was
remarkably constant, varying between 7.1 and 9.0 picosiemens (Table I and Fig. 6),
with the exception of L591C having Li+ conductance of
6.4 ± 0.31 (p < 0.05 versus wild
type). Among the mutations associated with changes in
Li+/Na+ selectivity, W582C was the only
mutant that exhibited an inward whole cell Na+ current that
was significantly greater than the inward Li+ current
(Figs. 4 and 5). The single channel slope conductance of
W582C , measured with Na+ as the permeating ion,
was 7.9 picosiemens, approximately twice that of wild type
  ENaC (Table I and Fig. 6). The single channel Li+/Na+ conductance ratio of 0.96 differed from
the Li+/Na+ whole cell current ratio of 0.59 measured from W582C mENaC. Other investigators have used both
single channel analyses and whole cell current measurements to examine
cation selectivity of selected ENaC mutants and have also noted that
these two methods may yield dissimilar results (12).
View this table:
[in this window]
[in a new window]
|
Table I
Single channel slope conductances of wild type (WT) and selected
mutants
GNa and GLi are slope
conductances of Na+ and Li+ inward currents calculated
by linearly fitting measured inward currents in the presence of
Na+ or Li+ solution as both bath and pipette solution
against negative values of pipette potentials in the range of 40, 60, 80, and 100 mV. Data are presented as mean ± S.E.
|
|

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 6.
Single channel recordings of wild type
(WT) and
W582C
mENaC. A and B, single channel current
traces recorded in 110 mM Na+ or
Li+ solutions (bath and pipette) from oocytes injected with
  mENaC (A) or W582C mENaC (B)
cRNAs. The closed state is indicated as C. Voltages are
negative values of applied pipette potentials during recording.
Downward deflections indicate inward current.
C, current-voltage relationship of Na+ and
Li+ currents in the range of 100 to 40 mV through wild
type (WT) mENaC ( ) or W582C -mENaC ( ). Data
are presented as mean ± S.E. for 4-7 recordings.
Lines were obtained by fitting the data with linear
regression.
|
|
Channels with cysteine substitutions at either -Gly587
or -Ser589 expressed measurable whole cell
amiloride-sensitive K+ currents (Figs. 4 and
7). The K+/Na+
current ratios for G587C and S589C were 0.23 ± 0.10 (n = 5) and 1.76 ± 0.22 (n = 6), respectively (Table II). Neither mutant showed a significant change in Li+/Na+
selectivity from wild type channels. To further explore the role of
residues at positions -Gly587 and -Ser589
in determining cation selectivity, additional mutations were generated,
including G587A, G587S, G587T, S589A, S589G, and S589T. As observed with a cysteine mutation at position
-Gly587, an alanine substitution at this site also
resulted in channels that were K+-permeable, as determined
by measurement of amiloride-sensitive inward K+ currents.
The K+/Na+ current ratio for G587A was
0.80 ± 0.16 (n = 7; Table II and Fig. 7).
Introduction of an alanine or a glycine residue at position -Ser589 also resulted in a mutant channel that was
K+-permeable. The K+/Na+ current
ratio for S589A was 0.56 ± 0.21 (n = 4;
Table II and Fig. 7); the K+/Na+ current ratio
for S589G was 0.32 ± 0.09 (n = 6;
Table II and Fig. 8). However,
retention of the hydroxyl moiety on the side chain at position
-Ser589 ( S589T), or introduction of a hydroxyl moiety
on the side chain at position -Gly587 ( G587S) allowed
channels to discriminate Na+ from K+. The
K+/Na+ current ratios for G587S and
S589T were 0.03 ± 0.03 (n = 4) and
0.04 ± 0.02 (n = 5), respectively, and did not
differ significantly from wild type (Table II and Fig. 7). No
amiloride-sensitive currents were detected in oocytes expressing
G587T and bathed in either K+, Na+,
and Li+ solutions. Although G587C and
S589C exhibited Li+/Na+ current ratios
similar to that of wild type, other mutations at positions
-Gly587 and -Ser589 did alter the
channel's Li+/Na+ current ratio (Table II).
The mutant G587A exhibited a Li+/Na+
current ratio of 0.97 ± 0.17 (n = 7). The mutants
S589A , S589T , and S589G expressed inward
Na+ currents that were greater than inward Li+
currents, with Li+/Na+ current ratios of
0.88 ± 0.39 (n = 4), 0.86 ± 0.21 (n = 5), and 0.96 ± 0.07 (n = 6),
respectively.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 7.
Selected point mutations of
G587 and S589 alter
K+/Na+ selectivity. Current-voltage
relationships of the mENaC mutants S589C , S589A ,
S589T , G587C , G587A , and G587S were
obtained by measuring amiloride-sensitive currents in the presence of
K+ ( ), Na+ , or Li+ ( )
bath solution while varying the test potential in the range of 140 mV
(or 100 mV for -Ser589 mutants) to +40 mV in 20-mV
increments. Data are presented without curve fitting as mean ± S.E. for 4-7 oocytes.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Selectivity changes from mutations at positions
Gly587-Ser589 of mENaC
Current ratios were calculated from amiloride-sensitive currents
measured at 100 mV in oocytes expressing wild type (WT) or mutant
mENaC together with - and mENaC subunits in the presence of
100 mM K+, Na+, or Li+ both
solutions. Data are presented as mean ± S.E.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 8.
Mutation of GSS (residues
-Gly587- -Ser589)
to GYG renders the channel K+-selective.
A-C, representative whole cell currents recorded in oocytes
expressing a mutant   mENaC containing a GYG tract at residues
587- 589 in the presence of 100 mM K+
(A), Na+ (B), or Li+
(C) bath solutions. Current traces in the presence of 100 µM amiloride are shown in panels on the
right. D, current-voltage relationship of mutant
  mENaCs containing the GYG mutation within the -subunit was
obtained by plotting amiloride-sensitive currents in the presence of
K+ ( ), Na+ ( ), or Li+ ( )
against test potentials varying from 140 mV to +40 mV. E,
current-voltage relationship of S589G mENaC was obtained as in
D. Data are presented as mean ± S.E. from six
oocytes.
|
|
Our results suggest that a limited domain within the pore region of
mENaC, -Gly587 through -Ser589, has a
critical role in restricting K+ permeation through the
channel, since selected mutations within this region alter
K+/Na+ selectivity. This GSS tract within
-subunit is conserved within the -subunit (GGS) and -subunit
(SCS) of ENaC. Selected mutations within this limited domain of each of
the three subunits alter K+/Na+ selectivity
(11, 12, 14), suggesting that a (G/S)XS tract restricts
K+ transport through the channel. Interestingly, a G(Y/F)G
tract within voltage-gated, Ca2+-dependent, and
inwardly rectifying K+ channels is a critical site for
determining K+ selectivity (15, 24-27). Therefore, we
examined whether substitution of the GSS tract (residues 587-589)
within mENaC with GYG ( S588Y, S589G) rendered the mutant
channel K+-selective (Table II and Fig. 8). The
K+/Na+ current ratio of this mutant was
3.92 ± 1.09 (n = 7). This mutant did not
discriminate Li+ and Na+, since the
Li+/Na+ current ratio of this mutant was
1.06 ± 0.30 (n = 7).
Barium chloride at a concentration of 5 mM was included in
bath solutions in the present study to minimize the background amiloride-insensitive currents from endogenous K+ channels
in oocytes. Removal of Ba2+ from the bath solution had no
effect on the amiloride-sensitive Na+ currents measured in
oocytes expressing wild type   , W582C , G587C ,
S589C , or the GYG mutant ( S588Y- S589G ).
Increased amiloride-insensitive currents were observed in some oocytes. Another set of experiments in which bath solutions containing chloride
(rather than gluconate) as the anion and no Ba2+ produced
similar results in cation selectivity for wild type   ,
G587S , and S588Y- S589G (data not shown).
 |
DISCUSSION |
The generation of cysteine mutations systematically throughout the
pore region of the -subunit of mENaC (residues
-Val569 to -Ser592) allowed us to examine
the role of residues within this region in conferring cation
selectivity. Two distinct domains within this pore region were defined
based on analyses of these mutants. Within the N-terminal portion of
this region, corresponding to residues -Val569 through
-Gly579, mutations resulted in minimal changes in cation
selectivity or amiloride sensitivity. Within this region, a reduced
Li+/Na+ current ratio was observed only with
the mutant S573C, and an altered (reduced) Ki for
amiloride was observed with the mutant L575C. In contrast, changes
in amiloride sensitivity or cation selectivity were observed with all
of the mutants within the carboxyl-terminal portion of this domain
( -Ser580 to -Ser592), with the exception
of W585C.
Previous studies of amiloride-induced block of ENaC suggest that this
diuretic is a pore blocker and interacts with the external side of the
pore (10, 28, 29). In addition, amiloride appears to interact at other
sites within the channel protein, including sites within the ectodomain
(30-32). As amiloride interacts with the channel pore, it is likely
that selected mutations within the outer pore region of ENaC will alter
the channel's interaction with this drug. We observed that within the
carboxyl-terminal portion of the pore region (residues
-Ser580 through -Ser592), cysteine
substitutions at 9 of 13 residues resulted in mutant channels with
increased Ki values for amiloride (Fig. 2). However,
these changes in amiloride's Ki were modest, particularly when compared with the nearly 1000-fold increase in
Ki observed with a single mutation within the pore region of the - or -subunit of mouse ( G525C and G542C) and rat ENaC ( G525C and G537C). These glycine residues within rat - and ENaC are located within the pore region, and Schild
et al. (10) have proposed that rat -Gly525
and -Gly537 are important sites for amiloride binding.
Given their observations, it is somewhat surprising that we found only
modest changes in amiloride's Ki in our analyses of
mutations throughout the pore region of the -subunit. Murine
-Gly525 and -Gly542 are within a region
that is highly conserved among the three ENaC subunits (Fig.
1C). The residue within mENaC corresponding to
-Gly525 and -Gly542 is
-Ser583, and previous studies have demonstrated that
substitution of a cysteine residue at this site results in only a
modest increase in amiloride's Ki (4, 10). We
confirmed this observation, although we have not examined whether other
mutations at this residue ( -Ser583) result in larger
changes in amiloride's Ki. Our results raise the
question of whether the previously identified amiloride binding sites
(residues -Gly525 and -Gly537 within rat
ENaC) are directly involved in the interaction of amiloride within the
channel's pore. An alternative hypothesis is that these mutations
alter the structure of the channel's pore and indirectly affect
amiloride's interaction with the pore.
We examined the effects of mutations within the pore region of the
mENaC on cation selectivity, as determined by amiloride-sensitive current ratios. Within the C-terminal portion of the pore region, cysteine mutations introduced at multiple residues between
-Ser580 and -Phe586 and a cysteine
mutation introduced at -Ser592 were associated with
significant changes in Li+/Na+ selectivity
(Figs. 4 and 5). Although the G587C and S589C mutants did not
alter Li+/Na+ selectivity, other mutations at
these sites including G587A, S589A, S589G, and S589T
significantly altered the Li+/Na+ current ratio
(Table II and Fig. 7). Surprisingly, cysteine mutations within the pore
region of the -subunit did not appreciably alter single channel
Li+ conductance (Table I), with the exception of L591C.
The changes in Li+/Na+ selectivity we observed
with mutations within this region may reflect changes in single channel
Na+ conductance, as we observed with W582C, although we
cannot rule out the possibility that these mutations affect other
parameters, such as open probability.
Channels with substitutions at either position -Gly587
or -Ser589 expressed low whole cell amiloride-sensitive
Na+ currents in oocytes (less than 0.5 µA) with the
exception of S589T and S589G. In contrast, Kellenberger et
al. (11, 12) reported currents in the range of 15-36 µA when rat
-Gly587 was mutated to Ala or Ser or when rat
-Ser589 was mutated to Ala, Cys, or Asp and then
co-expressed with wild type rat - and ENaC in Xenopus
oocytes. However, these amiloride-sensitive whole cell currents were
markedly reduced when compared with currents measured in oocytes
expressing wild type rat ENaC.
The W582C and F586C mutants exhibited
Li+/Na+ selectivity ratios that were
significantly lower than that observed with wild type mENaC. These data
suggest that these aromatic residues might have a role in providing a
site within the pore that interacts with Li+ and
Na+ in a differential manner. Aromatic amino acid residues
have been shown to interact with monovalent cations through cation-
interactions (33-35). Our data raise the possibility that tryptophan
and phenylalanine residues within a limited domain of the pore region
provide binding sites that favor small cations and perhaps discriminate
Na+ from Li+. Alternatively, the aromatic
residues might face away from the pore and interact with other residues
within the channel to allow the pore to maintain an appropriate
diameter to confer cation selectivity. The introduction of mutations at
these sites might affect pore diameter and cation selectivity. A
proposed role of -Trp582 and -Phe586 in
ion permeation through ENaC is consistent with studies performed on
other cation-selective channels with aromatic amino acid residues within their pore regions that are thought to have a role in conferring ion selectivity (36, 37). We did not detect a significant change in
cation selectivity following cysteine substitution of another
tryptophan ( W585C) that is conserved among all three subunits of
ENaC as well as Deg-1, Mec-4, and FaNaCh (Fig. 1C). However,
Kellenberger et al. (12) observed a modest but significant reduction of ILi/INa with
W585C as well as with selected mutations at the corresponding
residues within the - and -subunits ( -Trp527 and
-Trp539). In contrast, Snyder et al. (14)
reported no change in Li+/Na+ and
K+/Na+ selectivity with the equivalent mutation
within human ENaC (W538C). Given these data, it is still unclear
whether this conserved tryptophan residue has an important functional
role within ENaC's selectivity filter.
The 7-residue tract ( -Ser580- -Phe586)
where cysteine substitutions lead to changes in
Li+/Na+ selectivity of ENaC is adjacent to a
GSS tract (residues -Gly587- -Ser589)
that is conserved within the ENaC/degenerin superfamily (Fig. 1C). Cysteine substitutions of either -Gly587
or -Ser589 significantly increased the K+
permeability of the channel. Our results demonstrating that mutations at position -Ser589 ( S589A and S589C) increase
K+ permeability are largely in agreement with results
reported by Kellenberger et al. (11). However, the
significant change in K+/Na+ selectivity we
observed with selected mutations at position -Gly587
( G587C or G587A) differs from results reported by Kellenberger et al., where both G587S and G587A showed no
K+ permeability (12). Our observation that two distinct
mutations at this site ( G587C or G587A) resulted in measurable
amiloride-sensitive whole cell K+ currents provides strong
evidence that this residue has an important role in restricting
K+ permeation through the pore. Furthermore, our
observation that the G587S mutation resulted in no significant
change in cation selectivity is in agreement with the results of
Kellenberger et al. (12). Interestingly, Kellenberger
et al. observed a significant increase in
IK/INa with mutations at
rat G529 ( G529C and G529S), a position analogous to mouse and
rat -Gly587 (12). An equivalent mutation in human
ENaC ( S540C) displayed a 5-fold increase in the
Li+/Na+ current ratio without an effect on the
K+/Na+ current ratio (14). These data, taken
together, suggest that the limited (G/S)XS tract within the
three ENaC subunits restricts K+. This tract is remarkably
reminiscent of the G(Y/F)G tract within the pore region of
K+-selective cation channels that has been identified as a
key site for conferring cation selectivity based on mutagenesis and
x-ray crystallographic studies (15, 24-27). Substitution of GSS
(residues -Gly587- -Ser589) in mENaC
with the residues GYG altered the cation selectivity of mENaC such that
the channel was primarily K+-selective, with a
K+/Na+ current ratio of 3.9 (Table II and Fig.
8). This is the most K+-selective mutant that we observed
in our analyses of the 30 mutants that were generated within the pore
region of the -subunit. These data suggest that the ENaC pore may
share some degree of structural similarity with the pore of the KscA
K+ channel.
Substitution of amino acid residues with hydroxyl groups (serine or
threonine) at position -Gly587 or -Ser589
( G587S and S589T) resulted in channels that retained wild type K+/Na+ selectivity. We observed that
substitution of other residues at position -Gly587 or
-Ser589 ( G587C, G587A, S589C, S589A,
S589G) led to significant increases in
K+/Na+ selectivity. The weaver mouse
has a serine for glycine substitution within the GYG tract (residues
156-158) of the pore region of a G protein-gated inwardly rectifying
K+ channel (G156S) (38). Interestingly, channels with the
weaver mutation were permeable to both Na+ and
K+, suggesting that the presence of a serine residue at
this site may be important for allowing Na+ to pass through
the channel (39-41). Taken together, these data suggest that serine or
threonine residues within the GSS tract of the -subunit of ENaC have
a role in conferring Na+ selectivity. However, one caveat
is that we have been unable to detect measurable amiloride-sensitive
whole cation (Na+, Li+, or K+)
currents when G587T was expressed in oocytes.
Proposed Models for ENaC Selectivity Filter: ENaC Selectivity Is
Achieved through Cation Interactions at Multiple Sites within the
Selectivity Filter--
The changes in cation selectivity we observed
with mutations within the carboxyl-terminal portion of the pore domain
suggest that residues within this region, whose secondary structure is predicted to contain an extended region, line the selectivity filter of
the channel. We propose a selectivity model whereby ENaC selectivity is
achieved through multiple sites within the outer pore region (Fig.
9). Our results suggest that there are a
minimum of two critical sites within the pore region of mENaC that
are primarily responsible for K+/Na+ and
Li+/Na+ selectivity. A permeant ion must pass
both sites, or "barriers," to traverse the membrane. One
selectivity site is formed by the (G/S)XS tract (residues
-Gly587- -Ser589 within mENaC). This
site is responsible for excluding K+ and presumably
divalent cations according to the size of the dehydrated ion, allowing
both Li+ and Na+ to traverse the site. We
propose that K+ is excluded from this site on the basis of
size, since its dehydrated radius (1.33 Å) is too large to pass
through this site. Changes in the diameter of the pore might be
expected to alter interactions with Na+ (or
Li+) and lead to changes in the
Li+/Na+ selectivity ratio, as we observed with
the G587A, S589A, S589G, and S589T mutants. We propose that
cations pass a second site that consists of a tract including residue
-Trp582 (Fig. 9). Since several mutations within the
(G/S)XS tract are K+-permeable, this second site
does not appear to strictly exclude K+. Tryptophan residues
are proposed to stabilize dehydrated cations via cation-
interactions (33, 34), and it is conceivable that the
Trp582 side chain extends into the pore's lumen and
participates in solvation of cations. Alternatively, backbone carbonyl
residues extend into the pore lumen, and the tryptophan side chain
interacts with other residues within the channel to maintain
appropriate channel diameter.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 9.
ENaC selectivity models. A, a
model of the ENaC selectivity filter with two crucial sites formed by
1) the GXS tract (residues -Gly587
- -Ser589, indicated as S589) and 2)
-Trp582 (W582). The GXS site is
external to the -Trp582 site. B, a similar
model to A; however, the GXS is internal to
-Trp582. C, an illustration of the
arrangement of amino acids within the pore and M2 regions of ENaC. This
model was generated based on evidence suggesting that the N-terminal
portion of the pore may form an -helix (51) and that the
carboxyl-terminal portion of the pore containing the selectivity filter
exists as an extended or random-coiled region. The pore domain enters
and then exits the outer face of the membrane, similar in structure to
the KcsA K+ channel (15). M2 is shown as an -helical
structure that begins at the outer face of the plasma membrane.
-Trp582, -Gly587, and
-Ser589 are placed within the proposed selectivity
filter as in model A. D and E, alternative
topologies of the pore region and M2 are illustrated. In these
structures, the pore and M2 regions span the membrane from its outer to
its inner face. -Trp582, -Gly587, and
-Ser589 are placed within the proposed selectivity
filter region as in model B. The membrane-spanning pore region is ~33
residues in length ( -Ser580- -Leu612). To
accommodate these 33 residues within the membrane, we speculate that
the M2 domain must reside at an angle to the membrane normal. Two
models are presented (D and E), with different
orientations of M2 within the membrane. The placement of the
amino-terminal portion of the pore region in D and
E was arbitrary, given the limited available information
that would predict its location within the pore.
|
|
Our results and recent analyses of the putative pore region of the
channel suggest several models of how the ENaC pore is arranged (Fig.
9). One model, proposed by Kellenberger et al. and Snyder
et al. (11, 12, 14), has the pore region extending from an
extracellular site directly into the -helical second membrane-spanning domain, analogous to two funnels joined together by
their spouts (Fig. 9D). In this proposed structure, the pore enters the membrane and narrows to a region containing the selectivity filter that is an extended structure of up to 10 residues in length ( -Ser580- -Ser589). We propose that the
pore transitions to an -helical second membrane-spanning domain and
that the pore widens as it undergoes this transition to facilitate high
rates of throughput in a putative aqueous environment.
Our data suggest that selectivity does not reside at single site but
that multiple sites are involved in this process. We propose that
residues -Ser580 through -Ser589 form an
extended selectivity filter and that residues -Leu591
(or -Ser592) through -Leu612 (or
-Arg616) form an -helical membrane-spanning domain.
This is contrast to the pore model proposed by Kellenberger et
al. (11) and Snyder et al. (14), who suggested that the
selectivity filter is formed solely by the (G/S)XS tract.
Amiloride is proposed to interact with a portion of the channel within
the membrane-spanning domain and with specific residues within the -
and -subunits in positions analogous to -Ser583 (10).
If all residues within the proposed selectivity filter and -helical
M2 domain ( -Ser580 through -Leu612) are
present within the region of the channel spanning the membrane (or
lipid bilayer), the putative membrane-spanning region would extend for
a minimum of 33 residues in length. This would comprise an
extraordinarily long membrane-spanning tract if the residues are
arranged in a somewhat linear or -helical fashion (Fig. 9, D and E). For example, the second
membrane-spanning domain of the KcsA channel is 28 residues in length
and is tilted with respect to the membrane normal by 25° (15).
An alternative pore region structure would also be consistent with our
data. This structure, analogous to the pore of the KcsA K+
channel, is formed by a pore -helix that enters the membrane followed by an extended region directed toward the ectodomain of the
channel (Fig. 9C). This extended region forms the
selectivity filter. We propose that this region within mENaC is
~10 residues in length and is similar in length to the selectivity
filter of the KcsA K+ channel, which has 7 residues (15). A
turn region (or loop) is then followed by the -helical second
membrane-spanning domain. This model is not consistent with the notion
that amiloride interacts directly with -Gly525 and
-Gly542. However, mutations at these residues might
result in changes in the structure of the pore that indirectly alter
amiloride's Ki (see above). Our observation that
substitution of the GSS tract (residues
-Gly587- -Ser589) in mENaC with GYG
led to a K+-selective cation channel is also consistent
with the notion that the ENaC pore may be similar in structure to the
pore of the KscA K+ channel (Fig. 9C).
We and others have identified residues in homologous regions within the
-, -, and -subunits that probably participate in forming the
pore of the channel (11, 12, 14). However, our results do not exclude
the possibility that other residues participate in permeation of
cations through ENaC. Other residues could be involved in the
permeation process by helping to maintain the structure of the
selectivity filter. For example, we observed a modest but significant
reduction in the Li+/Na+ current ratio with the
S573C mutation. If the channel pore has a structure similar to the
KcsA channel, -Ser573 might be present within the pore
helix and interact through hydrogen bonding with residues within the
selectivity filter. Mutation of Ser573 might affect pore
helix-selectivity filter interactions and alter both the overall
conformation of the selectivity filter and the channel's ionic
selectivity. Mutation at residue -Ser592 altered
Li+/Na+ selectivity (Figs. 4 and 5), in
agreement with previous observations of Waldmann et al.
(13), although a mutation of the corresponding residue within human
ENaC to alanine (C541A) resulted in no significant change in either
Li+/Na+ or K+/Na+
selectivity (14). This residue (Ser592 within mouse and rat
ENaC) might be located at the transition site where the extended
C-terminal portion of the pore region of the -subunit transitions to
the -helical M2 domain (Fig. 9C). We propose that
mutations at this site alter Li+/Na+
selectivity by changing the conformation of the adjacent selectivity filter, although we cannot exclude the possibility that
-Ser592 is within the selectivity filter.
Mutations within the amino-terminal putative cytoplasmic domain of the
related cation channel ASIC2 altered the channel's cation selectivity
(42), and residues preceding the pore region altered the cation
(Na+/K+) selectivity of bovine -subunit
channels expressed in planar lipid bilayers (31). These data suggest
that additional sites may have a role in determining the cation
selectivity of ENaC.
In summary, our results suggest that the selectivity filter within the
-subunit of ENaC is formed by an extended region (C-terminal half of
the pore region), including residues -Ser580 through
-Ser589. Our data suggest that there are at least two
regions within this domain that have sites where cation discrimination
occurs and are consistent with the hypothesis that that the ENaC pore has multiple barriers that a Na+ ion must pass (43,
44).
 |
ACKNOWLEDGEMENTS |
We thank Drs. Thomas Kieber-Emmons and Farhad
Kosari for helpful discussions during the course of these studies and
Juliette Watts for the refinement of Fig. 9.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant DK54354 and a grant from the Department of Veterans Affairs.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of a postdoctoral fellowship award from the Cystic
Fibrosis Foundation.
§
To whom correspondence should be addressed: Renal Division, 700 Clinical Research Bldg., 415 Curie Blvd., Philadelphia, PA 19104-6144. Tel.: 215-573-1848; Fax: 215-898-0189; E-mail:
kleyman@mail.med.upenn.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
ENaC, epithelial
sodium channel;
mENaC, mouse ENaC.
 |
REFERENCES |
| 1.
|
Canessa, C. M.,
Horisberger, J. D.,
and Rossier, B. C.
(1993)
Nature
361,
467-470[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Canessa, C. M.,
Schild, L.,
Buell, G.,
Thorens, B.,
Gautschi, I.,
Horisberger, J. D.,
and Rossier, B. C.
(1994)
Nature
367,
463-467[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Firsov, D.,
Gautschi, I.,
Merillat, A. M.,
Rossier, B. C.,
and Schild, L.
(1998)
EMBO J.
17,
344-352[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Kosari, F.,
Sheng, S.,
Li, J.,
Mak, D.-O.,
Foskett, J. K.,
and Kleyman, T. R.
(1998)
J. Biol. Chem.
273,
13469-13474[Abstract/Free Full Text]
|
| 5.
|
Snyder, P. M.,
Cheng, C.,
Prince, L. S.,
Rogers, J. C.,
and Welsh, M. J.
(1998)
J. Biol. Chem.
273,
681-684[Abstract/Free Full Text]
|
| 6.
|
Eskandari, S.,
Snyder, P. M.,
Kreman, M.,
Zampighi, G. A.,
Welsh, M. J.,
and Wright, E. M.
(1999)
J. Biol. Chem.
274,
27281-27286[Abstract/Free Full Text]
|
| 7.
|
Canessa, C. M.,
Merillat, A. M.,
and Rossier, B. C.
(1994)
Am. J. Physiol.
267,
C1682-C1690[Abstract/Free Full Text]
|
| 8.
|
Snyder, P. M.,
McDonald, F. J.,
Stokes, J. B.,
and Welsh, M. J.
(1994)
J. Biol. Chem.
269,
24379-24383[Abstract/Free Full Text]
|
| 9.
|
Renard, S.,
Lingueglia, E.,
Voilley, N.,
Lazdunski, M.,
and Barbry, P.
(1994)
J. Biol. Chem.
269,
12981-12986[Abstract/Free Full Text]
|
| 10.
|
Schild, L.,
Schneeberger, E.,
Gautschi, I.,
and Firsov, D.
(1997)
J. Gen. Physiol.
109,
15-26[Abstract/Free Full Text]
|
| 11.
|
Kellenberger, S.,
Gautschi, I.,
and Schild, L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
4170-4175[Abstract/Free Full Text]
|
| 12.
|
Kellenberger, S.,
Hoffmann-Pochon, N.,
Gautschi, I.,
Schneeberger, E.,
and Schild, L.
(1999)
J. Gen. Physiol.
114,
13-30[Abstract/Free Full Text]
|
| 13.
|
Waldmann, R.,
Champigny, G.,
and Lazdunski, M.
(1995)
J. Biol. Chem.
270,
11735-11737[Abstract/Free Full Text]
|
| 14.
|
Snyder, P. M.,
Olson, D. R.,
and Bucher, D. B.
(1999)
J. Biol. Chem.
274,
28484-28490[Abstract/Free Full Text]
|
| 15.
|
Doyle, D. A.,
Cabral, J. M.,
Pfuetzner, R. A.,
Kuo, A.,
Gulbis, J. M.,
Cohen, S. L.,
Chait, B. T.,
and MacKinnon, R.
(1998)
Science
280,
69-77[Abstract/Free Full Text]
|
| 16.
|
Ahn, Y. J.,
Brooker, D. R.,
Kosari, F.,
Harte, B. J.,
Li, J.,
Mackler, S. A.,
and Kleyman, T. R.
(1999)
Am. J. Physiol.
277,
F121-F129[Abstract/Free Full Text]
|
| 17.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1995)
Current Protocols in Molecular Biology
, pp. 8.5.1-8.5.9, John Wiley & Sons, Inc., New York
|
| 18.
|
Benos, D. J.,
Mandel, L. J.,
and Simon, S. A.
(1980)
J. Gen. Physiol.
76,
233-247[Abstract/Free Full Text]
|
| 19.
|
Palmer, L. G.
(1982)
J. Membr. Biol.
67,
91-98[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Palmer, L. G.
(1987)
J. Membr. Biol.
96,
97-106[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Ismailov, I. I.,
Shlyonsky, V. G.,
Alvarez, O.,
and Benos, D. J.
(1997)
J. Physiol. (Lond.)
504,
287-300[Abstract/Free Full Text]
|
| 22.
|
Puoti, A.,
May, A.,
Canessa, C. M.,
Horisberger, J. D.,
Schild, L.,
and Rossier, B. C.
(1995)
Am. J. Physiol.
269,
C188-C197[Abstract/Free Full Text]
|
| 23.
|
McDonald, F. J.,
Price, M. P.,
Snyder, P. M.,
and Welsh, M. J.
(1995)
Am. J. Physiol.
268,
C1157-C1163[Abstract/Free Full Text]
|
| 24.
|
MacKinnon, R.,
and Yellen, G.
(1990)
Science
250,
276-279[Abstract/Free Full Text]
|
| 25.
|
Yellen, G.,
Jurman, M. E.,
Abramson, T.,
and MacKinnon, R.
(1991)
Science
251,
939-942[Abstract/Free Full Text]
|
| 26.
|
Yool, A. J.,
and Schwarz, T. L.
(1991)
Nature
349,
700-704[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Hoshi, T.,
and Zagotta, W. N.
(1993)
Curr. Opin. Neurobiol.
3,
283-290[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Palmer, L. G.
(1984)
J. Membr. Biol.
80,
153-165[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Hamilton, K. L.,
and Eaton, D. C.
(1985)
Am. J. Physiol.
249,
C200-C207[Abstract/Free Full Text]
|
| 30.
|
Ismailov, I. I.,
Kieber-Emmons, T.,
Lin, C.,
Berdiev, B. K.,
Shlyonsky, V. G.,
Patton, H. K.,
Fuller, C. M.,
Worrell, R.,
Zuckerman, J. B.,
Sun, W.,
Eaton, D. C.,
Benos, D. J.,
and Kleyman, T. R.
(1997)
J. Biol. Chem.
272,
21075-21083[Abstract/Free Full Text]
|
| 31.
|
Fuller, C. M.,
Berdiev, B. K.,
Shlyonsky, V. G.,
Ismailov, I. I.,
and Benos, D. J.
(1997)
Biophys. J.
72,
1622-32[Medline]
[Order article via Infotrieve]
|
| 32.
|
Busch, A. E.,
Suessbrich, H.,
Kunzelmann, K.,
Hipper, A.,
Greger, R.,
Waldegger, S.,
Mutschler, E.,
Lindemann, B.,
and Lang, F.
(1996)
Pflugers Arch. Eur. J. Physiol.
432,
760-766[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Kumpf, R. A.,
and Dougherty, D. A.
(1993)
Science
261,
1708-1710[Abstract/Free Full Text]
|
| 34.
|
Dougherty, D. A.
(1996)
Science
271,
163-168[Abstract]
|
| 35.
|
Dart, C.,
Leyland, M. L.,
Spencer, P. J.,
Stanfield, P. R.,
and Sutcliffe, M. J.
(1998)
J. Physiol. (Lond.)
511,
25-32[Abstract/Free Full Text]
|
| 36.
|
Tsushima, R. G.,
Li, R. A.,
and Backx, P. H.
(1997)
J. Gen. Physiol.
109,
463-475[Abstract/Free Full Text]
|
| 37.
|
Williams, K.,
Pahk, A. J.,
Kashiwagi, K.,
Masuko, T.,
Nguyen, N. D.,
and Igarashi, K.
(1998)
Mol. Pharmacol.
53,
933-941[Abstract/Free Full Text]
|
| 38.
|
Patil, N.,
Cox, D. R.,
Bhat, D.,
Faham, M.,
Myers, R. M.,
and Peterson, A. S.
(1995)
Nat. Genet.
11,
126-129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Kofuji, P.,
Hofer, M.,
Millen, K. J.,
Millonig, J. H.,
Davidson, N.,
Lester, H. A.,
and Hatten, M. E.
(1996)
Neuron
16,
941-952[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Tong, Y.,
Wei, J.,
Zhang, S.,
Strong, J. A.,
Dlouhy, S. R.,
Hodes, M. E.,
Ghetti, B.,
and Yu, L.
(1996)
FEBS Lett.
390,
63-68[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Slesinger, P. A.,
Patil, N.,
Liao, Y. J.,
Jan, Y. N.,
Jan, L. Y.,
and Cox, D. R.
(1996)
Neuron
16,
321-331[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Coscoy, S.,
de Weille, J. R.,
Lingueglia, E.,
and Lazdunski, M.
(1999)
J. Biol. Chem.
274,
10129-10132[Abstract/Free Full Text]
|
| 43.
|
Palmer, L. G.
(1990)
Ren. Physiol. Biochem. Pharmacol.
13,
51-58
|
| 44.
|
Ismailov, I. I.,
Awayda, M. S.,
Berdiev, B. K.,
Bubien, J. K.,
Lucas, J. E.,
Fuller, C. M.,
and Benos, D. J.
(1996)
J. Biol. Chem.
271,
807-816[Abstract/Free Full Text]
|
| 45.
|
King, R. D.,
and Sternberg, M. J.
(1996)
Protein Sci.
5,
2298-2310[Medline]
[Order article via Infotrieve]
|
| 46.
|
Garnier, J.,
Osguthorpe, D. J.,
and Robson, B.
(1978)
J. Mol. Biol.
120,
97-120[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Gibrat, J. F.,
Garnier, J.,
and Robson, B.
(1987)
J. Mol. Biol.
198,
425-443[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Guermeur, Y.,
Geourjon, C.,
Gallinari, P.,
and Deleage, G.
(1999)
Bioinformatics
15,
413-421[Abstract/Free Full Text]
|
| 49.
|
Rost, B.,
and Sander, C.
(1993)
J. Mol. Biol.
232,
584-599[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Frishman, D.,
and Argos, P.
(1996)
Protein Eng.
9,
133-142[Abstract/Free Full Text]
|
| 51.
|
Sheng, S.,
Avery, D.,
Kieber-Emmons, T.,
and Kleyman, T. R.
(1999)
J. Am. Soc. Nephrol.
10,
43[Abstract/Free Full Text] (abstr.)
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. B. Maarouf, N. Sheng, J. Chen, K. L. Winarski, S. Okumura, M. D. Carattino, C. R. Boyd, T. R. Kleyman, and S. Sheng
Novel Determinants of Epithelial Sodium Channel Gating within Extracellular Thumb Domains
J. Biol. Chem.,
March 20, 2009;
284(12):
7756 - 7765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Passero, G. M. Mueller, H. Rondon-Berrios, S. P. Tofovic, R. P. Hughey, and T. R. Kleyman
Plasmin Activates Epithelial Na+ Channels by Cleaving the {gamma} Subunit
J. Biol. Chem.,
December 26, 2008;
283(52):
36586 - 36591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Paukert, X. Chen, G. Polleichtner, H. Schindelin, and S. Grunder
Candidate Amino Acids Involved in H+ Gating of Acid-sensing Ion Channel 1a
J. Biol. Chem.,
January 4, 2008;
283(1):
572 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Carattino, C. J. Passero, C. A. Steren, A. B. Maarouf, J. M. Pilewski, M. M. Myerburg, R. P. Hughey, and T. R. Kleyman
Defining an inhibitory domain in the {alpha}-subunit of the epithelial sodium channel
Am J Physiol Renal Physiol,
January 1, 2008;
294(1):
F47 - F52.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Golubovic, A. Kuhn, M. Williamson, H. Kalbacher, T. W. Holstein, C. J. P. Grimmelikhuijzen, and S. Grunder
A Peptide-gated Ion Channel from the Freshwater Polyp Hydra
J. Biol. Chem.,
November 30, 2007;
282(48):
35098 - 35103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Mueller, O. B. Kashlan, J. B. Bruns, A. B. Maarouf, M. Aridor, T. R. Kleyman, and R. P. Hughey
Epithelial Sodium Channel Exit from the Endoplasmic Reticulum Is Regulated by a Signal within the Carboxyl Cytoplasmic Domain of the {alpha} Subunit
J. Biol. Chem.,
November 16, 2007;
282(46):
33475 - 33483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Yan, L. Spruce, M. M. Rosenblatt, T. R. Kleyman, and R. C. Rubenstein
Intracellular trafficking of a polymorphism in the COOH terminus of the {alpha}-subunit of the human epithelial sodium channel is modulated by casein kinase 1
Am J Physiol Renal Physiol,
September 1, 2007;
293(3):
F868 - F876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sheng, A. B. Maarouf, J. B. Bruns, R. P. Hughey, and T. R. Kleyman
Functional Role of Extracellular Loop Cysteine Residues of the Epithelial Na+ Channel in Na+ Self-inhibition
J. Biol. Chem.,
July 13, 2007;
282(28):
20180 - 20190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yu, D. C. Eaton, and M. N. Helms
Effect of divalent heavy metals on epithelial Na+ channels in A6 cells
Am J Physiol Renal Physiol,
July 1, 2007;
293(1):
F236 - F244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Anantharam, Y. Tian, and L. G. Palmer
Open probability of the epithelial sodium channel is regulated by intracellular sodium
J. Physiol.,
July 15, 2006;
574(2):
333 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Carattino, S. Sheng, J. B. Bruns, J. M. Pilewski, R. P. Hughey, and T. R. Kleyman
The Epithelial Na+ Channel Is Inhibited by a Peptide Derived from Proteolytic Processing of Its {alpha} Subunit
J. Biol. Chem.,
July 7, 2006;
281(27):
18901 - 18907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Pfister, I. Gautschi, A.-N. Takeda, M. van Bemmelen, S. Kellenberger, and L. Schild
A Gating Mutation in the Internal Pore of ASIC1a
J. Biol. Chem.,
April 28, 2006;
281(17):
11787 - 11791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Goldfarb, O. B. Kashlan, J. N. Watkins, L. Suaud, W. Yan, T. R. Kleyman, and R. C. Rubenstein
Differential effects of Hsc70 and Hsp70 on the intracellular trafficking and functional expression of epithelial sodium channels
PNAS,
April 11, 2006;
103(15):
5817 - 5822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Yan, L. Suaud, T. R. Kleyman, and R. C. Rubenstein
Differential modulation of a polymorphism in the COOH terminus of the {alpha}-subunit of the human epithelial sodium channel by protein kinase C{delta}
Am J Physiol Renal Physiol,
February 1, 2006;
290(2):
F279 - F288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. B. Kashlan, S. Sheng, and T. R. Kleyman
On the Interaction between Amiloride and Its Putative {alpha}-Subunit Epithelial Na+ Channel Binding Site
J. Biol. Chem.,
July 15, 2005;
280(28):
26206 - 26215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sheng, C. J. Perry, O. B. Kashlan, and T. R. Kleyman
Side Chain Orientation of Residues Lining the Selectivity Filter of Epithelial Na+ Channels
J. Biol. Chem.,
March 4, 2005;
280(9):
8513 - 8522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Carattino, S. Sheng, and T. R. Kleyman
Mutations in the Pore Region Modify Epithelial Sodium Channel Gating by Shear Stress
J. Biol. Chem.,
February 11, 2005;
280(6):
4393 - 4401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Paukert, E. Babini, M. Pusch, and S. Grunder
Identification of the Ca2+ Blocking Site of Acid-sensing Ion Channel (ASIC) 1: Implications for Channel Gating
J. Gen. Physiol.,
September 27, 2004;
124(4):
383 - 394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. F. Samaha, R. C. Rubenstein, W. Yan, M. Ramkumar, D. I. Levy, Y. J. Ahn, S. Sheng, and T. R. Kleyman
Functional Polymorphism in the Carboxyl Terminus of the {alpha}-Subunit of the Human Epithelial Sodium Channel
J. Biol. Chem.,
June 4, 2004;
279(23):
23900 - 23907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Hughey, J. B. Bruns, C. L. Kinlough, K. L. Harkleroad, Q. Tong, M. D. Carattino, J. P. Johnson, J. D. Stockand, and T. R. Kleyman
Epithelial Sodium Channels Are Activated by Furin-dependent Proteolysis
J. Biol. Chem.,
April 30, 2004;
279(18):
18111 - 18114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-L. Ji, L. R. Bishop, S. J. Anderson, C. M. Fuller, and D. J. Benos
The Role of Pre-H2 Domains of {alpha}- and {delta}-Epithelial Na+ Channels in Ion Permeation, Conductance, and Amiloride Sensitivity
J. Biol. Chem.,
February 27, 2004;
279(9):
8428 - 8440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Carattino, S. Sheng, and T. R. Kleyman
Epithelial Na+ Channels Are Activated by Laminar Shear Stress
J. Biol. Chem.,
February 6, 2004;
279(6):
4120 - 4126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Kelly, C. Lin, M. Ramkumar, N. C. Saxena, T. R. Kleyman, and D. C. Eaton
Characterization of an amiloride binding region in the {alpha}-subunit of ENaC
Am J Physiol Renal Physiol,
December 1, 2003;
285(6):
F1279 - F1290.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Kellenberger, I. Gautschi, and L. Schild
Mutations in the Epithelial Na+ Channel ENaC Outer Pore Disrupt Amiloride Block by Increasing Its Dissociation Rate
Mol. Pharmacol.,
October 1, 2003;
64(4):
848 - 856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Bruns, B. Hu, Y. J. Ahn, S. Sheng, R. P. Hughey, and T. R. Kleyman
Multiple epithelial Na+ channel domains participate in subunit assembly
Am J Physiol Renal Physiol,
October 1, 2003;
285(4):
F600 - F609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Babini, H.-S. Geisler, M. Siba, and S. Grunder
A New Subunit of the Epithelial Na+ Channel Identifies Regions Involved in Na+ Self-inhibition
J. Biol. Chem.,
August 1, 2003;
278(31):
28418 - 28426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, S. Sheng, C. J. Perry, and T. R. Kleyman
Asymmetric Organization of the Pore Region of the Epithelial Sodium Channel
J. Biol. Chem.,
April 11, 2003;
278(16):
13867 - 13874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sheng, C. J. Perry, and T. R. Kleyman
External Nickel Inhibits Epithelial Sodium Channel by Binding to Histidine Residues within the Extracellular Domains of alpha and gamma Subunits and Reducing Channel Open Probability
J. Biol. Chem.,
December 13, 2002;
277(51):
50098 - 50111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kellenberger, I. Gautschi, and L. Schild
An External Site Controls Closing of the Epithelial Na+ Channel ENaC
J. Physiol.,
September 1, 2002;
543(2):
413 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kellenberger and L. Schild
Epithelial Sodium Channel/Degenerin Family of Ion Channels: A Variety of Functions for a Shared Structure
Physiol Rev,
July 1, 2002;
82(3):
735 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Snyder
The Epithelial Na+ Channel: Cell Surface Insertion and Retrieval in Na+ Homeostasis and Hypertension
Endocr. Rev.,
April 1, 2002;
23(2):
258 - 275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sheng, K. A. McNulty, J. M. Harvey, and T. R. Kleyman
Second Transmembrane Domains of ENaC Subunits Contribute to Ion Permeation and Selectivity
J. Biol. Chem.,
November 16, 2001;
276(47):
44091 - 44098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. Dudeja
A potential second ion permeability barrier of the epithelial Na+ channel: Focus on "Point mutations in the post-M2 region of human {alpha}-ENaC regulate cation selectivity"
Am J Physiol Cell Physiol,
July 1, 2001;
281(1):
C15 - C16.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-L. Ji, S. Parker, A. L. B. Langloh, C. M. Fuller, and D. J. Benos
Point mutations in the post-M2 region of human {alpha}-ENaC regulate cation selectivity
Am J Physiol Cell Physiol,
July 1, 2001;
281(1):
C64 - C74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Satlin, S. Sheng, C. B. Woda, and T. R. Kleyman
Epithelial Na+ channels are regulated by flow
Am J Physiol Renal Physiol,
June 1, 2001;
280(6):
F1010 - F1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sheng, J. Li, K. A. McNulty, T. Kieber-Emmons, and T. R. Kleyman
Epithelial Sodium Channel Pore Region. STRUCTURE AND ROLE IN GATING
J. Biol. Chem.,
January 5, 2001;
276(2):
1326 - 1334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-L. Bassler, T. J. Ngo-Anh, H.-S. Geisler, J. P. Ruppersberg, and S. Grunder
Molecular and Functional Characterization of Acid-sensing Ion Channel (ASIC) 1b
J. Biol. Chem.,
August 31, 2001;
276(36):
33782 - 33787.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|